Evidence map›Paper›PMID 21254230›Full record

ReviewJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2011

The amazing osteocyte.

Lynda F Bonewald

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,092 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,092citing papers in PubMed, 2 pooled it
42.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,092 citing papers in PubMed, 2 syntheses or guidelines pooled it, 2,184 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. S100A9 Induces RANKL Expression in Osteocytes Utilizing IL-6/sIL-6R Combination and gp130 Signaling Pathways.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Extracellular vesicle-mediated crosstalk in bone: miR-150-5p as a mechanosensitive regulator of osteoclastogenesis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  20. Article

1,032 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lynda F BonewaldDepartment of Oral Biology, University of Missouri-Kansas City, Kansas City, MO 64108-2784, USA. Bonewaldl@umkc.edu
University of Missouri–Kansas City · US

Funding

Transgenic CoreP01AR046798 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI BONEWALD, LYNDA F · 2001 to 2010
$10.5M
Muscle-Bone Endocrine AxisRC2AR058962 · NIAMS · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F, BROTTO, MARCO · 2009 to 2010
$1.1M
NIAMS NIH HHS AR-46798NIAMS NIH HHS P01 AR046798NIAMS NIH HHS RC2 AR058962NIAMS NIH HHS RC2-AR058962
6 · The paper itself

Abstract

The last decade has provided a virtual explosion of data on the molecular biology and function of osteocytes. Far from being the "passive placeholder in bone," this cell has been found to have numerous functions, such as acting as an orchestrator of bone remodeling through regulation of both osteoclast and osteoblast activity and also functioning as an endocrine cell. The osteocyte is a source of soluble factors not only to target cells on the bone surface but also to target distant organs, such as kidney, muscle, and other tissues. This cell plays a role in both phosphate metabolism and calcium availability and can remodel its perilacunar matrix. Osteocytes compose 90% to 95% of all bone cells in adult bone and are the longest lived bone cell, up to decades within their mineralized environment. As we age, these cells die, leaving behind empty lacunae that frequently micropetrose. In aged bone such as osteonecrotic bone, empty lacunae are associated with reduced remodeling. Inflammatory factors such as tumor necrosis factor and glucocorticoids used to treat inflammatory disease induce osteocyte cell death, but by different mechanisms with potentially different outcomes. Therefore, healthy, viable osteocytes are necessary for proper functionality of bone and other organs.

Indexed as

AnimalsBone and BonesBone RemodelingCalciumCell SurvivalGlucocorticoidsHumansInflammationMiceModels, BiologicalOsteocytesPhosphatesTumor Necrosis Factor-alphaCalciumGlucocorticoidsPhosphatesTumor Necrosis Factor-alpha

Identifiers

PMID21254230
PMCPMC3179345
OpenAlexW2019582558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.